Ignite Creation Date:
2024-05-06 @ 7:48 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06144619
Status:
RECRUITING
Last Update Posted:
2024-05-09
First Post:
2023-11-16
Brief Title:
Non-Invasive Biomarkers in Prostate Cancer Disease Management
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Study Overview
Official Title:
Non-Invasive Biomarkers in Prostate Cancer Disease Management
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is an observational retrospective prospective study with diagnosed lowintermediate risk no-surgery high risk surgery prostate cancer that are eligible and willing to undergo standard of care SOC assessment annually along with biopsies bio-fluid collection Participants will obtain genomic and histological evaluation on their biopsied samples Study follows SOC collection with additional body fluid collection blood urine Biopsysurgery will not require additional sample collection
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None